Donor immune cells tested to stop deadly cancers from returning
NCT ID NCT06730009
Summary
This study is testing whether adding donor immune cells (called NK cells) to standard chemotherapy helps prevent cancer from coming back after surgery. It will involve about 42 adults with pancreatic or bile duct cancer who have had their tumor surgically removed. The research first aims to find a safe dose of the immune cells, then test if the cell-plus-chemo combination works better than chemotherapy alone.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PANCREATIC CARCINOMA STAGE II are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
National Cheng Kung University Hospital
RECRUITINGTainan, 138, Taiwan
Contact
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.